Firaxis Games, maker of strategy franchises like XCOM and Civilization franchise, is cutting 60 staff members today, or about a third of its total workforce.
The studio’s last release, Sid Meier’s Civilization VII, dropped last year and has Mixed reviews on Steam. But according to Bloomberg’s Jason Schreier, the team “has also been working on a new XCOM game that has faced development struggles and missed a significant milestone over the summer,” sources say.

Other than Civ 7, Firaxis has also launched Marvel’s Midnight Suns in 2022, XCOM: Chimera Squad in 2020, and Civilization 6 in 2016. Presumably, XCOM 3 is potentially the title up next after XCOM 2 launched in 2016.
“Firaxis is restructuring and recentering around the studio’s core strength—designing world class strategy games that have set the industry standard for the genre for the last 30 years,” a 2K Games spokesperson said in a statement about the layoffs. “As part of these changes, the size of the studio is being reduced to focus on design, technology, and the player experience, which means saying goodbye to talented colleagues who helped build Firaxis. These decisions are never easy, but they’re essential to build the next chapter of Firaxis.”
Firaxis is owned by Take-Two Interactive and operated by its 2K Games label. Take-Two will release Grand Theft Auto 6 this week, and it’s expected to make billions in revenue, though that’s unfortunately not enough to keep many Firaxis staff around to finish their current project.
I’m a big fan of XCOM and think Midnight Suns was massively underrated, so it’s a huge bummer to see this news come out today, especially since it was seemingly meant to coincide with Take-Two’s other big game coming out and get lost within that hype. I hope the affected devs land on their feet soon.
The struggles for Firaxis and even Bit Reactor—which houses many former Firaxis devs and released Star Wars: Zero Company to positive reviews earlier this year but still had to furlough around 80 percent of its staff before launch—call into question the overall profitability and marketability of the strategy genre when it comes to keeping shareholders satisfied.